Related Experiment Videos
Pemoline, methylphenidate, and placebo in children with minimal brain dysfunction
Archives of General Psychiatry
|August 1, 1980
Summary
This study compared pemoline (Cylert) and methylphenidate (Ritalin) in hyperactive children. Both medications improved behavior, but pemoline showed longer-lasting effects after treatment withdrawal compared to methylphenidate.
Area of Science:
- Pediatric Neurology
- Child Psychiatry
- Pharmacology
Background:
- Hyperactivity in children is a significant concern impacting development.
- Pharmacological interventions are commonly used to manage symptoms of hyperactivity.
Purpose of the Study:
- To compare the efficacy and duration of action of pemoline (Cylert) and methylphenidate (Ritalin) versus placebo in hyperactive children.
- To assess the impact of these medications on various behavioral and cognitive domains.
Main Methods:
- An eight-week, double-blind, placebo-controlled study involving 60 hyperactive children.
- Evaluations included home, school, achievement, cognitive function, and clinical status assessments at multiple time points.
Main Results:
- Both pemoline and methylphenidate demonstrated significant improvements in home, school, and clinical status compared to placebo.
- Neither drug showed improvement in achievement measures.
- Pemoline exhibited a longer duration of action, with effects persisting post-treatment, unlike methylphenidate which showed regression to baseline.
Conclusions:
- Pemoline and methylphenidate are effective in managing hyperactivity symptoms.
- Pemoline may offer a sustained therapeutic benefit beyond the treatment period, suggesting a different pharmacokinetic or pharmacodynamic profile compared to methylphenidate.